Source: Genomeweb

Rebus Bio: Rebus Biosystems, Rosalind to Codevelop Spatial Omics Analysis Software

The companies hope to make single-cell spatial omics data from the Rebus Esper system accessible for researchers without a deep bioinformatics background.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Paul Sargeant's photo - CEO of Rebus Bio

CEO

Paul Sargeant

CEO Approval Rating

90/100

Read more